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Mediterranean spotted fever (MSF) is a tick-borne disease caused by Rickettsia conorii. Recently,
complicated cases have been more frequently reported, even in previously healthy patients. We
describe a case of severe MSF complicated by acute renal failure and associated with herpetic
oesophagitis. Acyclovir therapy resulted in remission of oesophageal symptoms within 48 h.
Introduction
Mediterranean spotted fever (MSF) is a tick-borne disease
caused by Rickettsia conorii. In Italy about 400 cases are
reported every year. Nearly half occur in Sicily, which is
one of the most endemic regions. MSF is typically
characterized by fever, skin rash and a black eschar at the
site of the tick bite (‘tache noire’). At present, severe forms
are more frequently described and the current fatality rate
for MSF is increasing (Brouqui et al., 2007; Rovery et al.,
2008). Complications are described mainly in adult
patients, and include hepatic, renal, cardiac and neuro-
logical impairment. Severe complications can be prevented
by a prompt and efficacious antibiotic treatment. Diagnosis
is based on epidemiological, clinical and laboratory criteria
(Brouqui et al., 2007). We describe a case of severe MSF
complicated by acute renal failure and associated with
herpetic oesophagitis.
Case report
In August 2008 a 50-year-old Italian man was admitted to
the Infectious Diseases Unit of the University Hospital of
Palermo, Italy, because of continuous-remittent fever and
malaise of 6 days duration. A diffuse rash had appeared
the day before admission. An antibacterial therapy with
amoxicillin/clavulanate had been started at home without
an improvement of the symptoms.
In the patient’s medical history there was no evidence of
cardiac illness, diabetes mellitus, or hepatic, gastric or renal
dysfunctions. On admission, the patient appeared acutely
ill, with a maculo-papular rash with some petechial
elements involving the trunk and the extremities, including
palms and soles. Herpetiform skin lesions of 565 cm were
present on the upper lip and the nose. A single lesion of
20 mm in diameter surrounded by an inflammatory halo
with a small central crust was observed on the right leg.
Physical examination showed a diffusely tender abdomen
with significant splenomegaly and lower extremities
oedema. Results of cardiovascular, respiratory and neuro-
logical examinations were unremarkable. The patient’s
blood pressure was 120/70 mmHg and his body temper-
ature was 39.5 uC.
Laboratory examination demonstrated normal white and
red blood cell counts and a normal haemoglobin value, with
a low platelet count (51 000 cells ml21), and increased serum
urea (191 mg dl21), creatinine (6.1 mg dl21), aspartate
aminotransferase (469 IU l21), alanine aminotransferase
(229 IU l21) and C-reactive protein (26.77 mg dl21).
Coagulation parameters were within normal limits.
Creatinine clearance was 12.8 ml min21.
Chest X-ray showed a bilateral pleural effusion. An
abdominal ultrasound scan showed splenomegaly (trans-
verse diameter 17 cm) and a normal aspect of both
kidneys.
Because of a rash that was evocative of MSF, R. conorii
serological testing was performed and two blood samples were
collected for testing rickettsial DNA by real-time PCR using
primers for the citrate synthase-encoding gene, gltA (Stenos
et al., 2005). Treatment with 100 mg doxycycline twice daily
was started. Intravenous furosemide was administered
(20 mg, three times daily, for 5 days) to reduce the oedema
of the lower extremities and the bilateral pleural effusion.
The day after admission the patient complained of severe
retrosternal pain and odynophagia and presented with
melena. Oesophagogastroduodenoscopy (OGD) evidenced
severe ulcerative lesions with raised edges and exudative
bottoms throughout the entire oesophagus. There was
Abbreviations: HSV, herpes simplex virus; MSF, Mediterranean spotted
fever; OGD, oesophagogastroduodenoscopy.
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redness and punctiform bleeding of the antral mucosa.
Lesions were consistent with herpetic oesophagitis and
erosive gastritis. Oral acyclovir (800 mg daily for 10 days)
and omeprazole (20 mg twice daily for 7 days) were
prescribed, and remission of the oesophageal symptoms
was obtained after 48 h treatment.
Specific anti-rickettsia IgM and IgG determinations were
performed by an indirect immunofluorescence assay with
antigens obtained from a clinical isolate of R. conorii subsp.
conorii freshly prepared as described by Vitale et al. (1989).
An immunofluorescent antibody test for R. conorii showed
an increase of titres in two sera obtained after a 2 week
interval (first sample IgM 1 : 40 and IgG negative; second
sample IgM 1 : 1280 and IgG 1 : 640). Rickettsial DNA was
detected from both full blood and buffy coat samples with
a highly sensitive and specific real-time PCR assay for the
detection of spotted fever and typhus group Rickettsiae
using primers to the citrate synthase-encoding gene, gltA
(Stenos et al., 2005).
The ETI-HSVK-G enzyme immunoassay kit (Diasorin/
Sorin Diagnostics), a qualitative ELISA for the detection of
IgG antibodies to herpes simplex virus type 1 (HSV1) and/
or type 2 (HSV2) gB-1 antigens in human serum,
demonstrated a high titre of anti-HSV1 IgG.
Blood cultures were negative for aerobic/anaerobic bacteria,
mycobacteria and fungi. Results of serological tests were
negative for hepatitis viruses A, B and C, cytomegalovirus,
Epstein–Barr virus, Brucella spp., Leptospira spp., Salmonella
spp. and human immunodeficiency virus infections.
Immunological work-up showed normal CD4 levels.
Monitoring laboratory tests were strictly performed and
showed a progressive reduction in haemoglobin values
(7.5 g dl21) and diuresis (200 ml per day) for 1 week, while
a progressive defervescence and rash disappearance were
also observed.
At discharge, haematochemical values were within normal
ranges. The follow-up OGD 1 month after discharge
showed no oesophageal lesions.
Discussion
During the last few years rickettsial diseases have emerged
in several Mediterranean countries (Rovery et al., 2008;
Schmulewitz et al., 2008; Boillat et al., 2008; Weinberger
et al., 2008). Until the 1980s, MSF was thought to be a
benign illness with few complications and the propor-
tion of deaths was ,1%. In recent times, complicated
MSF cases have been reported, even in the absence of
predisposing conditions (Colomba et al., 2008; Leone et al.,
2008; Tsiachris et al., 2008; Tzavella et al., 2006). The
pathogenesis of MSF complications results from vascular
injury, which may be responsible for the dysfunction of
different organs (Brouqui et al., 2007; Rovery et al., 2008;
Schmulewitz et al., 2008). Our patient was previously
healthy. In particular, he denied any history of renal or
gastro-oesophageal disease. The only recognizable risk
factor for a severe form of MSF could be the inappropriate
antibacterial therapy that had been started at home and
that could have delayed the correct treatment.
Renal impairment has been frequently described as a
consequence of severe MSF. It has been observed that acute
renal failure was most strongly associated with a fatal
outcome (Sousa et al., 2008).
To the best of our knowledge, an association between MSF
and oesophagitis has never been reported. Oesophagitis
due to HSV1 is a well-recognized entity in immunocom-
promised patients but it has rarely been described in
immunocompetent hosts. It can represent either primary
infection or reactivation. In our patient the diagnosis of
HSV1 oesophagitis due to a reactivation of a primary
infection was based on the concomitant presence of herpes
labialis, characteristic endoscopic findings and HSV1
serological results. In our patient ulcerative lesions were
present throughout the entire oesophagus, and the follow-
up OGD 1 month after discharge showed no oesophageal
lesions.
Severe complications of herpetic oesophagitis, including
bleeding and oesophageal perforation, have rarely been
reported in immunocompetent hosts (Chien et al., 1992;
Cronstedt et al., 1992). Antiviral treatment of herpetic
oesophagitis in immunocompetent hosts is controversial
(Kurahara et al., 1998; Ramanathan et al., 2000). Early
initiation of acyclovir therapy was beneficial for our patient,
who had a striking response to the treatment within 48 h.
Our patient was affected by a severe MSF, complicated by
acute renal failure and associated with a rare clinical
picture of HSV1 reactivation. It can be supposed that a
more virulent R. conorii strain affected our patient, causing
the severe MSF. Acute renal failure could represent a
cofactor for a transient decline of immunological status so
that a latent herpetic infection could reactivate.
In conclusion, complicated MSF has to be taken into
account even in individuals without any underlying risk
factor. Severe MSF can be accompanied by clinical features
that are more frequently observed in immunocompro-
mised patients.
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